Clinical trial
A phase III randomised, double-blind parallel group extension study to investigate the safety and efficacy of twice daily administration of the free combination of linagliptin 2.5 mg + metformin 500 mg or of linagliptin 2.5 mg + metformin 1000 mg versus m
The objective of the current study is to investigate the safety and efficacy of linagliptin 2.5 mg plus metformin either 500 mg or 1000 mg, twice daily in comparison to metformin 1000 mg monotherapy twice daily given for 54 weeks.
| Category | Value |
|---|---|
| Study start date | 2009-05-15 |